IO Biotech Overview

IO Biotech Selling, General & Admin

Selling, General & Admin expenses for IOBT.

Quarterly SG&A Expenses

$5.61M

↓ 11.27% YoY

As of Sep 30, 2025

Annual SG&A Expenses (TTM)

$24.14M

↑ 1.01% YoY

Trailing 12 months ending Sep 30, 2025

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin